These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7915845)

  • 1. A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorder.
    Cutler NR; Hesselink JM; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 May; 18(3):447-63. PubMed ID: 7915845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
    Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
    J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety and efficacy of ipsapirone vs. lorazepam in outpatients with generalized anxiety disorder (GAD): single site findings from a multicenter trial.
    Cutler NR; Sramek JJ; Wardle TS; Hesselink JM; Roeschen JK
    Psychopharmacol Bull; 1993; 29(2):303-8. PubMed ID: 7904761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled double-blind multicenter trial of two doses of ipsapirone versus diazepam in generalized anxiety disorder.
    Boyer WF; Feighner JP
    Int Clin Psychopharmacol; 1993; 8(3):173-6. PubMed ID: 7903326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishing the maximum tolerated dose of lesopitron in patients with generalized anxiety disorder: a bridging study.
    Sramek JJ; Fresquet A; Marion-Landais G; Hourani J; Jhee SS; Martinez L; Jensen CM; Bolles K; Carrington AT; Cutler NR
    J Clin Psychopharmacol; 1996 Dec; 16(6):454-8. PubMed ID: 8959472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study.
    Fontaine R; Beaudry P; Beauclair L; Chouinard G
    Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR; Sramek JJ; Macpherson AE; Doss MG; Benes CO; Howard SF
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
    Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder.
    Czobor P; Skolnick P; Beer B; Lippa A
    CNS Neurosci Ther; 2010 Apr; 16(2):63-75. PubMed ID: 20041911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder.
    Ansseau M; Olié JP; von Frenckell R; Jourdain G; Stehle B; Guillet P
    Psychopharmacology (Berl); 1991; 104(4):439-43. PubMed ID: 1685793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of buspirone and diazepam in generalized anxiety disorder.
    Jacobson AF; Dominguez RA; Goldstein BJ; Steinbook RM
    Pharmacotherapy; 1985; 5(5):290-6. PubMed ID: 2866493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Buspirone: anxiolytic?
    Pecknold JC; Familamiri P; Chang H; Wilson R; Alarcia J; McClure DJ
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):639-42. PubMed ID: 2868495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of ipsapirone treatment compared with lorazepam: discontinuation effects.
    Busto UE; Naranjo CA; Bremner KE; Peachey JE; Bologa M
    J Psychiatry Neurosci; 1998 Jan; 23(1):35-44. PubMed ID: 9505058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of lesopitron in outpatients with generalized anxiety disorder.
    Fresquet A; Sust M; Lloret A; Murphy MF; Carter FJ; Campbell GM; Marion-Landais G
    Ann Pharmacother; 2000 Feb; 34(2):147-53. PubMed ID: 10676820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study.
    Llorca PM; Spadone C; Sol O; Danniau A; Bougerol T; Corruble E; Faruch M; Macher JP; Sermet E; Servant D
    J Clin Psychiatry; 2002 Nov; 63(11):1020-7. PubMed ID: 12444816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
    Feighner JP; Merideth CH; Hendrickson GA
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.